The simultaneous increase of IGF-1R and its associated mediators in the same set of samples in our current study can confirm the possible role of the IGF-1 axis on the change of ECM proteases in favor of bone cancer cell invasion. The gene discussed is IGF1; the disease is bone neoplasm.